Phase II study of B7–1 gene-modified autologous tumor cell vaccine and subcutaneous IL-2 for patients with stage IV renal cell carcinoma (RCC)

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 4502-4502 ◽  
Author(s):  
P. Thompson ◽  
M. Fishman ◽  
J. Seigne ◽  
M. Dunn ◽  
W. Janssen ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tumor Cell ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Stage Iv ◽  
Cell Vaccine ◽  
Autologous Tumor Cell ◽  
Autologous Tumor ◽  
Tumor Cell Vaccine ◽  
Autologous Tumor Cell Vaccine

FANG Vaccine: Autologous Tumor Cell Vaccine Genetically Modified to Express GM-CSF and Block Production of Furin

2010 ◽  
Vol 8 (4) ◽  
pp. 4-14 ◽  
Author(s):  
Phillip Maples ◽  
Padmasini Kumar ◽  
Yang Yu ◽  
Zhaohui Wang ◽  
Chris Jay ◽  
...  
Keyword(s):  
Tumor Cell ◽  
Genetically Modified ◽  
Cell Vaccine ◽  
Autologous Tumor Cell ◽  
Autologous Tumor ◽  
Tumor Cell Vaccine ◽  
Gm Csf ◽  
Autologous Tumor Cell Vaccine
Sign in / Sign up

Export Citation Format

Share Document